A.R. NAGIEVA¹, E.A. PRASKURNICHIY^{1, 3}, YU.S. KITAEVA^{1, 2}

 ¹Federal Medical Biophysical Center named after A.I. Burnasyan, Moscow

²Ural State Medical University, Ekaterinburg

³ N.I. Pirogov Russian National Research Medical University, Moscow

 Contact details:

Nagieva A.R. — postgraduate student of the Therapy Department

Address: 46/8 Zhivopisnaya St., Moscow, Russian Federation, 123098, tel.: +7 (999) 735-79-82, e-mail: nagieva281@gmail.com

Hodgkin’s lymphoma is more often diagnosed in young patients. One of the late complications of pathogenetic therapy of Hodgkin’s lymphoma is osteopenia/osteoporosis and the increased risk of low-energy fractures. Conducting densitometry in young patients in order to assess the bone tissue condition is advisable, but its clinical assessment remains difficult. At the same time, early diagnosis and prevention of bone mineral density decrease in patients with Hodgkin’s lymphoma who received antitumor therapy are very relevant.

The purpose — to study the features of densitometric indicators for the verification of osteopenia / osteoporosis in young patients with Hodgkin’s lymphoma.

Material and methods. 63 people were included in the study, 33 of them were patients with Hodgkin’s lymphoma who received pathogenetic therapy, and 30 people the control group — healthy volunteers. Bone mineral density was measured in all patients using the HOLOGIC (Hologic Inc., Bedford) in the lumbar spine (L1–L4) and in the hip area (the total area of the hip and hip neck). Criteria such as minimum bone mineral density, T-criteria and Z-criteria for young patients with Hodgkin’s lymphoma were determined.

Results. In the group of patients with Hodgkin’s lymphoma, a decrease in bone mineral density is significantly more often recorded in all measurement areas, as well as the Z-criterion in the lumbar spine. Regretfully, in young patients the T-criterion can only be used given a more intensive mineralization of bone tissue than in older people and the presence of additional risk factors for osteoporosis (PCTs, glucocorticosteroids, decreased androgenic and fertile function). In patients with HL who received pathogenetic therapy, a decrease in the T-criterion to osteopenia is more often observed in the proximal femur.

Conclusion. In many cases, modern capabilities for osteoporosis diagnostic allow correcting mineral metabolism in bone tissue and preventing the development of complications in young patients with Hodgkin’s lymphoma.

Key words: Hodgkin’s lymphoma, young age, osteoporosis, densitometric examination.

REFERENCES

1. Klinicheskie rekomendatsii RF “Osteoporoz” [Clinical recommendations of the Russian Federation “Osteoporosis”]. Moscow, 2021. 105 p.
2. Inaba H., Cao X., Han A.Q. et al. Bone mineral density in children with acute lymphoblastic leukemia. Cancer, 2018, vol. 124 (5), rr. 1025–1035.
3. Aibar-Almazán A., Voltes-Martínez A., Castellote-Caballero Y. et al. Current status of the diagnosis and management of osteoporosis. Int. J. Mol. Sci, 2022, vol. 23 (16), 9465 r.
4. Ruchlemer R., Amit-Kohn M., Tvito A., Sindelovsky I., Zimran A., Raveh-Brawer D. Bone loss and hematological malignancies in adults: a pilot study. Support Care Cancer, 2018, vol. 26 (9), rr. 3013–3020.
5. Adejuyigbe B., Kallini J., Chiou D. et al. Osteoporosis: molecular pathology, diagnostics, and therapeutics. Int. J. Mol. Sci, 2023, vol. 24 (19), 14583 r.
6. Karlovich N.V., Mokhort T.V., Sazonova E.G. Bone pathology in chronic kidney disease. Osteoporoz i osteopatii, 2022, vol. 25, no. 1, pp. 23–28 (in Russ.).
7. Kitaeva Yu.S., Praskurnichiy E.A. Predictors of decreased bone mineral density in patients with Hodgkin lymphoma associated with pathogenetic therapy. The Russian Archives of Internal Medicine, 2023, vol. 13, no. 1, pp. 36–45 (in Russ.).
8. Aylamazyan E.K. Ginekologiya ot pubertata do postmenopauzy [Gynecology from puberty to postmenopause]. Moscow: MEDpress-inform, 2007. 495 p.
9. Zotkin E.G., Kosul’nikova E.N. Osteoporosis: from organizing care for patients to treatment. Medlayn ekspress, 2007, vol. 1, no. 190, pp. 56–59 (in Russ.).
10. Abirova A.S., Kosmatova O.V., Novikov V.E. et al. Vozmozhnosti kostnoy rentgenovskoy densitometrii v klinicheskoy praktike: metodicheskie rekomendatsii. 2 izd., dop. [Possibilities of bone X-ray densitometry in clinical practice: methodological recommendations. 2nd ed., add.], 2015. 36 p.
11. Kanis J.A., Cooper C., Rizzoli R., Reginster J.-Y. Scientific advisory board of the european society for clinical and economic aspects of osteoporosis (ESCEO) and the Committees of scientific advisors and National Societies of the International osteoporosis foundation (IOF) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos. Int, 2019, vol. 30 (1), pp. 3–44.
12. Jang S., Graffy P.M., Ziemlewicz T.J. et al. Opportunistic osteoporosis screening at routine abdominal and thoracic CT: normative L1 trabecular attenuation values in more than 20,000 adults. Radiology, 2019, vol. 29 (291), pp. 360–367.
13. Wu X., Zhong J.Y., Wang G., Xu H.J. Factors relating to bone mineral density in young and middle-aged patients with ankylosing spondylitis. Chin. Med. J. (Engl), 2021, vol. 134 (21), pp. 2556–2563.
14. Praskurnichiy E.A., Kitaeva Yu.S., Kuznetsova E.V. Risk factors for the development of osteoporosis and osteopenia associated with pathogenetic therapy of Hodgkin lymphoma. Kremlevskaya meditsina. Klinicheskiy vestnik, 2022, vol. 1, no. 4, pp. 5–8 (in Russ.).